Dr. Reddy's Laboratories Files Form 6-K
Ticker: RDY · Form: 6-K · Filed: Aug 23, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
DRL filed a 6-K, confirming 20-F filings. Standard procedure.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on August 23, 2024, to report information as a foreign private issuer. The filing indicates the company will file annual reports under Form 20-F. The company's principal executive office is located in Hyderabad, Telangana, India.
Why It Matters
This filing is a routine disclosure for foreign private issuers, providing updates and confirming reporting status to the SEC.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-000933 (accession_number) — Filing identifier
- 20240823 (date) — Filing date
- Hyderabad, Telangana, India (location) — Principal executive office location
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information to the SEC.
Which form does Dr. Reddy's Laboratories Limited use for its annual reports?
Dr. Reddy's Laboratories Limited indicates it files annual reports under cover of Form 20-F.
Where is the principal executive office of Dr. Reddy's Laboratories Limited located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the SEC file number for Dr. Reddy's Laboratories Limited?
The SEC file number for Dr. Reddy's Laboratories Limited is 001-15182.
What is the SIC code for Dr. Reddy's Laboratories Limited?
The Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories Limited is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 401 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-08-23 08:19:30
Filing Documents
- drr0661_6k.htm (6-K) — 14KB
- drr0661_ex99-1.htm (EX-99.1) — 10KB
- drr0661_ex99-1img01.jpg (GRAPHIC) — 9KB
- drr0661_ex99-1img02.jpg (GRAPHIC) — 8KB
- 0001575872-24-000933.txt ( ) — 50KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: August 23, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3